The role of IL-4 and IL-4Ralpha in the multi-step process of Th2 development

IL-4 和 IL-4Ralpha 在 Th2 发育的多步骤过程中的作用

基本信息

  • 批准号:
    7184468
  • 负责人:
  • 金额:
    $ 39.94万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-11-15 至 2011-10-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Soil transmitted parasitic nematodes are world wide one of the most commonly acquired infections with multi-cellular parasites. The adaptive host response in humans and mice is characterized by the presence of CD4+ Th2 cells and their signature cytokine IL-4. Th2 cells and IL-4 are associated with protective immune responses against helminth parasites they are detrimental in certain immunopathologies such as antigen-induced asthmatic reactions, atopy and allergy. While Th2 cells are associated with nematode infections; however, it is not clear how Th2 cells develop from naive CD4+ T cells in response to infection. Numerous studies have shown that IL-4Ra-mediated signals and IL-4 are required for the Th2 development of naive CD4+ T cells in vitro, however, very little is known about these processes in vivo. This is largely due to the difficulty to identify and track Th2 cells defined by IL-4 expression. To overcome these limitations we have developed bicistronic IL-4 reporter (4get) mice. In contrast to in vitro studies, our preliminary data show that Th2 priming occurs surprisingly efficient in IL4Ra-/- 4get mice infected with the murine helminth H. polygyrus. Thus, the role of IL-4R and IL-4 for Th2 development is controversial. Recently we have generated novel IL-4 dual-reporter mice (4get/KN2) and revealed that IL-4 competence and IL-4 production are distinct steps. Here we propose a novel model whereby Th2 development and IL-4 production occur in several distinct, identifiable steps: 1. activation, 2. differentiation, 3. expansion, 4. IL-4 production, 5. dissemination. In the current application we will revisit the role of IL-4 and IL-4Ra-mediated signals for Th2 differentiation and IL-4 production using our unique dual-reporter mouse model. We hypothesize that IL-4R functions are not required to nucleate the Th2 priming of CD4+ T cells but play a role in multiple other steps of this model. In Aim 1 we will analyze which step(s) in Th2 differentiation of the endogenous T cell population are regulated by IL-4R signals in response to infection. In Aim 2 we will determine which step(s) in Th2 differentiation are regulated by IL-4R signals mediated directly on naive, antigen-specific CD4+ T cells. We will adoptively transfer apTCR transgenic CD4+ T cells and immunize with the cognate antigen using H. polygyrus larvae as a Th2 adjuvant. In Aim 3 we will dissect the role of IL-4 and IL-4Ra expression by selective lineages in the multi-step process of Th2 differentiation. We will generate various bone marrow chimeras which lack the respective components in selective cellular lineages and follow the development of the endogenous T helper response to infection. Collectively the proposed Aims will reveal the mechanism by which IL-4R and IL-4 regulate the multiple steps of Th2 development in vivo. These insights are valuable for designing agonistic and antagonistic intervention strategies targeting the IL-4R and IL-4.
描述(由申请人提供):土壤传播的寄生线虫是世界范围内最常见的多细胞寄生虫感染之一。人类和小鼠中的适应性宿主应答的特征在于存在CD 4 + Th 2细胞及其标志性细胞因子IL-4。Th 2细胞和IL-4与对抗蠕虫寄生虫的保护性免疫应答相关,它们在某些免疫病理学中是有害的,例如抗原诱导的哮喘反应、特应性和过敏。虽然Th 2细胞与线虫感染相关;然而,尚不清楚Th 2细胞如何响应于感染而从初始CD 4 + T细胞发育。 大量研究表明,IL-4 Ra介导的信号和IL-4是体外幼稚CD 4 + T细胞Th 2发育所必需的,然而,对这些体内过程知之甚少。这主要是由于难以识别和跟踪由IL-4表达定义的Th 2细胞。为了克服这些限制,我们开发了双顺反子IL-4报告基因(4get)小鼠。与体外研究相反,我们的初步数据表明,Th 2启动在感染鼠蠕虫H的IL 4 Ra-/- 4get小鼠中发生惊人的有效性。多脑回因此,IL-4 R和IL-4对Th 2发育的作用是有争议的。最近,我们已经产生了新的IL-4双报告小鼠(4get/KN 2),并揭示了IL-4的能力和IL-4的生产是不同的步骤。在这里,我们提出了一个新的模型,其中Th 2的发展和IL-4的生产发生在几个不同的,可识别的步骤:1。激活,2.差异化,3.膨胀,4. IL-4产生,5.传播。在本申请中,我们将使用我们独特的双报告小鼠模型重新审视IL-4和IL-4 Ra介导的信号对于Th 2分化和IL-4产生的作用。我们假设IL-4 R功能不需要使CD 4 + T细胞的Th 2启动成核,但在该模型的多个其他步骤中发挥作用。在目的1中,我们将分析内源性T细胞群体的Th 2分化中的哪些步骤由IL-4 R信号响应于感染来调节。在目标2中,我们将确定Th 2分化中的哪些步骤由直接介导于幼稚抗原特异性CD 4 + T细胞上的IL-4 R信号调节。我们将过继转移apTCR转基因CD 4 + T细胞,并使用H.多脑回幼虫作为Th 2佐剂。在目的3中,我们将通过选择性谱系来剖析IL-4和IL-4 Ra表达在Th 2分化的多步骤过程中的作用。我们将产生各种骨髓嵌合体,这些嵌合体在选择性细胞谱系中缺乏相应的成分,并跟踪内源性T辅助细胞对感染的反应的发展。总的来说,所提出的目的将揭示IL-4 R和IL-4调节体内Th 2发育的多个步骤的机制。这些见解对于设计针对IL-4 R和IL-4的激动性和拮抗性干预策略是有价值的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARKUS MOHRS其他文献

MARKUS MOHRS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARKUS MOHRS', 18)}}的其他基金

MoFlo XDP High Speed Cell Sorter
MoFlo XDP 高速细胞分选仪
  • 批准号:
    7793781
  • 财政年份:
    2010
  • 资助金额:
    $ 39.94万
  • 项目类别:
The interdependence between T and B cells in Th2 cell differentiation
Th2细胞分化中T细胞和B细胞之间的相互依赖性
  • 批准号:
    8099628
  • 财政年份:
    2008
  • 资助金额:
    $ 39.94万
  • 项目类别:
The interdependence between T and B cells in Th2 cell differentiation
Th2细胞分化中T细胞和B细胞之间的相互依赖性
  • 批准号:
    8282924
  • 财政年份:
    2008
  • 资助金额:
    $ 39.94万
  • 项目类别:
The interdependence between T and B cells in Th2 cell differentiation
Th2细胞分化中T细胞和B细胞之间的相互依赖性
  • 批准号:
    7627355
  • 财政年份:
    2008
  • 资助金额:
    $ 39.94万
  • 项目类别:
The interdependence between T and B cells in Th2 cell differentiation
Th2细胞分化中T细胞和B细胞之间的相互依赖性
  • 批准号:
    7881631
  • 财政年份:
    2008
  • 资助金额:
    $ 39.94万
  • 项目类别:
The interdependence between T and B cells in Th2 cell differentiation
Th2细胞分化中T细胞和B细胞之间的相互依赖性
  • 批准号:
    7525536
  • 财政年份:
    2008
  • 资助金额:
    $ 39.94万
  • 项目类别:
Functional cloning of S. mansoni egg-specific Th2 cells
曼氏沙门氏菌卵特异性 Th2 细胞的功能克隆
  • 批准号:
    7240385
  • 财政年份:
    2007
  • 资助金额:
    $ 39.94万
  • 项目类别:
Functional cloning of S. mansoni egg-specific Th2 cells
曼氏沙门氏菌卵特异性 Th2 细胞的功能克隆
  • 批准号:
    7476341
  • 财政年份:
    2007
  • 资助金额:
    $ 39.94万
  • 项目类别:
The role of IL-4 and IL-4Ralpha in the multi-step process of Th2 development
IL-4 和 IL-4Ralpha 在 Th2 发育的多步骤过程中的作用
  • 批准号:
    7725827
  • 财政年份:
    2006
  • 资助金额:
    $ 39.94万
  • 项目类别:
The role of IL-4 and IL-4Ralpha in the multi-step process of Th2 development
IL-4 和 IL-4Ralpha 在 Th2 发育的多步骤过程中的作用
  • 批准号:
    7989122
  • 财政年份:
    2006
  • 资助金额:
    $ 39.94万
  • 项目类别:

相似海外基金

Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
  • 批准号:
    23K08213
  • 财政年份:
    2023
  • 资助金额:
    $ 39.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
  • 批准号:
    2881726
  • 财政年份:
    2023
  • 资助金额:
    $ 39.94万
  • 项目类别:
    Studentship
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
  • 批准号:
    10722146
  • 财政年份:
    2023
  • 资助金额:
    $ 39.94万
  • 项目类别:
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
  • 批准号:
    10735090
  • 财政年份:
    2023
  • 资助金额:
    $ 39.94万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 39.94万
  • 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
  • 批准号:
    10935776
  • 财政年份:
    2023
  • 资助金额:
    $ 39.94万
  • 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
  • 批准号:
    10935796
  • 财政年份:
    2023
  • 资助金额:
    $ 39.94万
  • 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
  • 批准号:
    10935775
  • 财政年份:
    2023
  • 资助金额:
    $ 39.94万
  • 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
  • 批准号:
    10649041
  • 财政年份:
    2023
  • 资助金额:
    $ 39.94万
  • 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
  • 批准号:
    10735964
  • 财政年份:
    2023
  • 资助金额:
    $ 39.94万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了